 | Up a level |
Journal Article
Baillet, Athan, Gossec, Laure, Carmona, Loreto 
ORCID: 0000-0002-4401-2551, de Wit, Maarten, van Eijk-Hustings, Yvonne, Bertheussen, Heidi, Alison, Kent, Toft, Mette, Kouloumas, Marios, Ferreira, Ricardo J. O., Oliver, Susan, Rubbert-Roth, Andrea, van Assen, Sander, Dixon, William G., Finckh, Axel, Zink, Angela, Kremer, Joel, Kvien, Tore K., Nurmohamed, Michael, van der Heijde, Desiree ORCID: 0000-0002-5781-158X and Dougados, Maxime
(2016).
Points to consider for reporting, screening for and preventing selected comorbidities in chronic inflammatory rheumatic diseases in daily practice: a EULAR initiative.
Ann. Rheum. Dis., 75 (6).
S. 965 - 974.
LONDON:
BMJ PUBLISHING GROUP.
ISSN 1468-2060
Burmester, Gerd R., McInnes, Iain B., Kremer, Joel, Miranda, Pedro, Korkosz, Mariusz, Vencovsky, Jiri ORCID: 0000-0002-0851-0713, Rubbert-Roth, Andrea, Mysler, Eduardo, Sleeman, Matthew A., Godwood, Alex, Sinibaldi, Dominic, Guo, Xiang, White, Wendy I., Wang, Bing, Wu, Chi-Yuan, Ryan, Patricia C., Close, David and Weinblatt, Michael E.
(2017).
A randomised phase IIb study of mavrilimumab, a novel GM-CSF receptor alpha monoclonal antibody, in the treatment of rheumatoid arthritis.
Ann. Rheum. Dis., 76 (6).
S. 1020 - 1031.
LONDON:
BMJ PUBLISHING GROUP.
ISSN 1468-2060
Haraoui, Boulos, Sebba, Anthony, Rubbert-Roth, Andrea, Scali, Juan, Alten, Rieke, Kremer, Joel, Pitts, Laura, Vernon, Emma, van Vollenhoven, Ronald and Genovese, Mark (2014). Long-Term Safety of Tocilizumab in Patients with Rheumatoid Arthritis following a Mean Treatment Duration of 3.9 Years. J. Rheumatol., 41 (7). S. 1508 - 1509. TORONTO: J RHEUMATOL PUBL CO. ISSN 1499-2752